Comparación de formulaciones de Semaglutida y herramientas de inyección para la consistencia de los niveles sanguíneos

This study focuses on comparing different versions of a medication called semaglutide, and various injection tools used to administer it. The goal is to demonstrate that these different versions of semaglutide result in similar levels in the bloodstream. This research is important as it aims to ensure that new versions of semaglutide are as effective as the ones currently prescribed by doctors. The study is designed for participants who will receive two versions of semaglutide during two separate dosing visits. One version will be the currently prescribed one, and the other will be a new version. The order in which participants receive these versions is decided randomly. During the study, participants will receive semaglutide as an injection under the skin, with a gap of 7 to 8 weeks between injections. The study will last approximately 16 weeks and will involve 27 visits to the study doctor. For two of these visits, participants will stay at the clinic for 4 days and 3 nights. The study measures the effectiveness of semaglutide by looking at the area under the plasma semaglutide concentration curve from time 0 until the last quantifiable measurement after a single dose. It also measures the maximum plasma semaglutide concentration after a single dose. These measurements help determine how well the body responds to different versions of semaglutide.